Atlas Trials

The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Clinical trial NCT05057923 · COMPLETED

Trial details

NCT number
NCT05057923
Sponsor
DreamTec Research Limited
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2021-07-10
Primary completion
2021-10-20
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.